Empagliflozin attenuates doxorubicin-induced cardiotoxicity
Toxicol Res (Camb)
.
2023 Aug 31;12(5):998.
doi: 10.1093/toxres/tfad071.
eCollection 2023 Oct.
Authors
Veysel Özgür Barış
1
2
,
Adnan Berk Dinçsoy
2
,
Esra Gedikli
2
,
Selim Zırh
3
,
Sevda Müftüoğlu
3
,
Ayşen Erdem
2
Affiliations
1
Department of Cardiology, Dr. Ersin Arslan Research and Education Hospital, Gaziantep 27010, Turkey.
2
Department of Physiology, Hacettepe University Faculty of Medicine, Ankara 06230, Turkey.
3
Department of Histology, Hacettepe University Faculty of Medicine, Ankara 06230, Turkey.
PMID:
37915469
PMCID:
PMC10615805
(available on
2024-08-31
)
DOI:
10.1093/toxres/tfad071
No abstract available